Literature DB >> 4340159

3':5'-cyclic adenosine monophosphate phosphodiesterase: negative cooperativity.

T R Russell, W J Thompson, F W Schneider, M M Appleman.   

Abstract

Kinetic and chromatographic analysis of cyclic nucleotide phosphodiesterase (EC 3.1.4.c) obtained from rat tissue has revealed that this enzyme exists in at least two molecular forms. After chromatographic separation, one form (cyclic AMP phosphodiesterase) still exhibits kinetics suggestive of the action of either two enzymes or one enzyme under negative cooperative regulation. Computer model studies were undertaken to distinguish between these two possibilities. The matrix method was used to generate the partition functions for (a) the sum of two independent enzymes and (b) one enzyme exhibiting negative cooperative kinetics. The experimental data were fitted to the theoretical models by a nonlinear least-squares computer program. The results show that, while both models can fit the data, the two-enzyme model would require contamination far in excess of what is detectable physically or by activity measurements. Thus, the negative cooperative model seems the more appropriate theoretical explanation of the observed kinetic behavior of this enzyme. The implication of negative cooperativity with respect to the regulation of cyclic AMP concentrations in physiological systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4340159      PMCID: PMC426803          DOI: 10.1073/pnas.69.7.1791

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Preparation and properties of a cyclic 3',5'-nucleotide phosphodiesterase isolated from frog erythrocytes.

Authors:  O M Rosen
Journal:  Arch Biochem Biophys       Date:  1970-04       Impact factor: 4.013

2.  The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

Authors:  G Brooker; L J Thomas; M M Appleman
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

3.  Negative cooperativity in enzyme action. The binding of diphosphopyridine nucleotide to glyceraldehyde 3-phosphate dehydrogenase.

Authors:  A Conway; D E Koshland
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

4.  The enzymic degradation of 3',5' cyclic AMP in strains of E. Coli sensitive and resistant to catobolite repression.

Authors:  D Monard; J Janecek; H V Rickenberg
Journal:  Biochem Biophys Res Commun       Date:  1969-05-22       Impact factor: 3.575

5.  Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain.

Authors:  W Y Cheung
Journal:  Biochemistry       Date:  1967-04       Impact factor: 3.162

6.  Purification and properties of 3',5'-cyclic nucleotide phosphodiesterase from dog heart.

Authors:  K G Nair
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

7.  Co-operative subunit protein models and the matrix method.

Authors:  F W Schneider; T R Russell; P K Rawlings
Journal:  J Mol Biol       Date:  1970-02-28       Impact factor: 5.469

8.  Negative cooperativity in regulatory enzymes.

Authors:  A Levitzki; D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

9.  Comparison of experimental binding data and theoretical models in proteins containing subunits.

Authors:  D E Koshland; G Némethy; D Filmer
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

10.  Cyclic 3',5'-adenosine monophosphate phosphodiesterase produced by the slime mold Dictyostelium discoideum.

Authors:  Y Y Chang
Journal:  Science       Date:  1968-07-05       Impact factor: 47.728

View more
  10 in total

1.  Localization of 3', 5'-cyclic nucleotide phosphodiesterase activity in isolated thyroid cells and intact thyroid tissue.

Authors:  A E Kalderon; S F Ravanshenas
Journal:  Histochemistry       Date:  1974-05-03

2.  Theoretical analysis of the consequences of cyclic nucleotide phosphodiesterase negative co-operativity. Amplification and positive co-operativity of cyclic AMP accumulation.

Authors:  C Erneux; J M Boeynaems; J E Dumont
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

3.  Isoelectric-focusing patterns of cyclic nucleotide phosphodiesterase from rat heart.

Authors:  G Némoz; A F Prigent; J F Pageaux; H Pacheco
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

4.  Patterns of cyclic AMP phosphodiesterases during rat testis development.

Authors:  J T Epplen; W Engel; J Schmidtke
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

5.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.

Authors:  M L Reeves; B K Leigh; P J England
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.

Authors:  J Silvola; M Kangasaho; O Tokola; H Vapaatalo
Journal:  Agents Actions       Date:  1982-10

7.  Diurnal changes in cyclic nucleotide levels in the hypothalamus of the rat.

Authors:  C Valases; S J Wright; G N Catravas
Journal:  Exp Brain Res       Date:  1980       Impact factor: 1.972

8.  Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+.

Authors:  S Kakiuchi; R Yamazaki; Y Teshima; K Uenishi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

9.  Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.

Authors:  I Mullaney; R A Clegg
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

10.  Short-term binding and hydrolysis of cyclic 3':5'-adenosine monophosphate by aggregating Dictyostelium cells.

Authors:  D Malchow; G Gerisch
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.